| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005545 Plasmid comprising heterologous viral gene sequences for diagnosis, prevention and treatment of respiratory system disorders; vaccine development; viricides |
| 01/08/2004 | US20040005367 Methods of treating necrotizing enterocolitis |
| 01/08/2004 | US20040005360 Core-and-shell dosage form or unit in which the core contains API and in which the shell substantially governs the release such as by controlling diffusion of API through the shell. The shell may comprise a release-blocking polymer, and particles |
| 01/08/2004 | US20040005335 Oral compositions for HIV-infected subjects |
| 01/08/2004 | US20040005331 Polypeptides and fragments of polypeptides containing histidine triad residues or coiled-coil regions, some of which polypeptides or fragments lie between 80 and 680 residues in length. Also disclosed are processes for |
| 01/08/2004 | US20040005325 Helicobacter felis vaccine |
| 01/08/2004 | US20040005323 Efficient method for generating human antibodies in particular which are specific to be RSV fusion protein which combines in vitro primary of human spleen cells and antigen boosting in SCID mice is taught. This method provides for very high human |
| 01/08/2004 | US20040005322 Compositions and methods related to TIM-3, a Th1-specific cell surface molecule |
| 01/08/2004 | US20040005318 Method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided. |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005298 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 01/08/2004 | US20040005276 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 01/08/2004 | DE10227668A1 Arzneimittel zur Behandlung des systemic inflammatory response syndrome Drugs for the treatment of systemic inflammatory response syndrome |
| 01/08/2004 | DE10227269A1 Thiazolderivate Thiazole derivatives |
| 01/08/2004 | CA2513143A1 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 01/08/2004 | CA2493646A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | CA2492135A1 Medicament for the treatment of diseases due to infection by neisseria meningitidis |
| 01/08/2004 | CA2492066A1 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | CA2492053A1 Peptides with antimicrobial properties and compounds containing same, particularly for preserving food |
| 01/08/2004 | CA2491859A1 Human igm antibody inducing apoptosis in hiv-infected cells and remedy for hiv-infection |
| 01/08/2004 | CA2491363A1 Antibodies and uses thereof |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2491034A1 Methods and materials for treating human papillomavirus infections |
| 01/08/2004 | CA2491001A1 Novel use of lipopeptide preparations |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490290A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | CA2490193A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
| 01/08/2004 | CA2490129A1 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | CA2490016A1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | CA2489675A1 Glycoalkaloid compositions and various uses thereof |
| 01/08/2004 | CA2489560A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | CA2489552A1 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 01/08/2004 | CA2489433A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2489411A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
| 01/08/2004 | CA2489090A1 Nutritional composition for detoxification and cancer prevention |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | CA2481890A1 Synergistic interaction of abacavir and alovudine |
| 01/08/2004 | CA2472438A1 Mannose binding protein for use in anti-hiv treatment |
| 01/07/2004 | EP1378516A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for HIV |
| 01/07/2004 | EP1378512A1 Optically pure camptothecin analogues |
| 01/07/2004 | EP1378509A1 Drugs containing triazaspiro 5.5]undecane derivatives as the active ingredient |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 01/07/2004 | EP1377660A2 Vaccine against the nile fever virus |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377606A1 Immunogenic cell surface proteins of helicobacter pylori |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377575A1 Antiviral pyrazolopyridine compounds |
| 01/07/2004 | EP1377574A1 6-phenylbenzonaphthyridines |
| 01/07/2004 | EP1377573A2 Pyrazolopyridine derivatives |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1377551A1 Antiproliferative agents |
| 01/07/2004 | EP1377549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
| 01/07/2004 | EP1377542A1 Hiv protease inhibitors based on amino acid derivatives |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377316A1 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 01/07/2004 | EP1377314A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 01/07/2004 | EP1377296A2 Antiviral method of use |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377275A2 Vaccine for modulating between t1 and t2 immune responses |
| 01/07/2004 | EP1377213A1 Method of predicting stroke evolution utilising mri |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1015467B1 6,9-bridged erythromycin derivatives |
| 01/07/2004 | CN1466680A Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 01/07/2004 | CN1466594A Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/07/2004 | CN1466591A Nucleoside derivatives |
| 01/07/2004 | CN1466578A Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
| 01/07/2004 | CN1466467A Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2004 | CN1466462A Method for producing agrimonia extract with improved activity against hepatitis Bvirus and pharmaceutical and flood compositions containing said extract |
| 01/07/2004 | CN1466460A Inhibition of systemic infectios in humans and vertebrates by dietary fibers |
| 01/07/2004 | CN1466459A 营养组合物 The nutritional composition |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1466454A Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465590A Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof |
| 01/07/2004 | CN1465574A L-nucleoside derivative and use thereof |
| 01/07/2004 | CN1465567A Dihydropyridone derivative and use thereof |
| 01/07/2004 | CN1465402A Recombination protein vaccine for preventing animal aphtha virus infection |
| 01/07/2004 | CN1465390A Artemisia apiacea pill for removing summer heat and curing cold |
| 01/07/2004 | CN1465378A Baicaoganfukang medicine for treating hepatophathy |
| 01/07/2004 | CN1465376A Medicinal composition containing zinc gluconate for resisting diplococcus pnenmonia |
| 01/07/2004 | CN1465371A Use of golden bell core or its extract in preparation of antibacterial and antivirus medicine or health care preparation |
| 01/07/2004 | CN1465360A Medicine for treating hepatopathy |
| 01/07/2004 | CN1465356A Nocar ointment for treating herpes simplex and herpes zoster |
| 01/07/2004 | CN1465354A Use of acellular short corynebacteria preparation in preparation of medicine for treating tuberculosis |
| 01/07/2004 | CN1465350A Toad skin preparation and productive process thereof |
| 01/07/2004 | CN1133642C Nucleoside 5'-thiophosphoryl amino-acid ester compound |
| 01/07/2004 | CN1133641C Thiophosphamino acid ester compound containing 3'-azido-deoxythymidine and its preparation process |